CoQ10 and Blood Pressure: The Supplement That Gently Lowers Hypertension

Every few years, a veteran supplement returns to the headlines with new data. Sometimes it's vitamin D found to be linked to overall mortality, sometimes it's omega-3 found to affect depression, and sometimes it's coenzyme Q10, a molecule found in every cell of the body and studied since 1957, repeatedly discovered to significantly lower hypertension. This time, the review came from Verywell Health on April 9, 2026, and it summarizes a body of evidence that has been accumulating for two decades.

The classic story of CoQ10 is a story about mitochondria and cellular energy. The new story, taking shape from dozens of clinical studies, is a story about blood vessels, endothelium, and nitric oxide. The two stories converge, and here precisely lies the biological explanation for why a relatively modestly priced supplement can lower blood pressure to an extent comparable to a prescription drug.

What is CoQ10 and Why is it Important

Coenzyme Q10, or ubiquinone, is a fat-soluble molecule found in every mitochondrial membrane in the human body. It plays two central roles:

• Electron carrier in the respiratory chain, an essential step in producing ATP, the energy currency of the cell.
• Powerful antioxidant in lipid membranes, protecting cell membranes from oxidative damage.
• Exists in two main forms: ubiquinone (the oxidized form) and ubiquinol (the reduced, more biologically active form).
• Body concentration drops by over 50% by age 80 compared to age 20, a significant decline in the heart, liver, and kidneys.
• Statins reduce the body's synthesis of CoQ10 by up to 40% as a side effect of inhibiting the mevalonate pathway.

This gap, between the increasing need with age and the sharp decline in internal production, is the biological basis explaining why external supplementation may benefit the elderly population specifically.

The Link to Blood Pressure: An Endothelial Mechanism

Hypertension in older age is not just a matter of fluids and salt; it is primarily a matter of the endothelial cell layer lining the inside of blood vessels. In young people, the endothelium efficiently produces nitric oxide (NO), a molecule that relaxes the vessel wall muscles and causes vasodilation. As we age, the ability to produce NO declines due to two processes: increased oxidative stress and damage to the mitochondria of the endothelial cells themselves.

This is where CoQ10 comes in. CoQ10 supplementation improves the mitochondrial function of endothelial cells, reduces oxidative stress, and thereby allows a return to normal nitric oxide production. Evidence for this came from direct measurements of flow-mediated dilation, the gold standard test for assessing endothelial function: after 8-12 weeks of CoQ10 at 200 mg per day, the dilation capacity of the brachial artery improves by 30-50% in patients with hypertension.

Additionally, CoQ10 affects other pathways related to blood pressure:

• Reducing sensitivity to angiotensin II, the central hormone that raises blood pressure.
• Improving large artery elasticity, a measure that declines sharply with age.
• Reducing aldosterone levels, especially in patients with metabolic syndrome.
• Improving left ventricular diastolic function, which reduces the load on the system.

Current Evidence

Study 1: Cochrane Meta-Analysis from 2016 (Updated in 2024)

The Cochrane review examined 17 controlled studies with 684 participants. The average reduction in systolic pressure was 11.1 mmHg, and in diastolic pressure 6.8 mmHg. A follow-up review from 2024 added 5 new studies and confirmed the findings: a statistically and clinically significant effect, with no serious side effects.

Study 2: Australian-British Meta-Analysis from 2023

Published in the Journal of Human Hypertension. Included 12 studies among 488 adults with uncontrolled hypertension. Over 8-12 weeks, a dose of 100-200 mg ubiquinol per day led to a reduction of 17 mmHg in systolic pressure and 10 mmHg in diastolic pressure. The effect was greater in people over age 60.

Study 3: LUSTRA Study from 2022 on Statins

A double-blind Australian study among 192 statin users who also had mild hypertension. Adding 200 mg CoQ10 per day led to an average reduction of 8.5 mmHg in systolic pressure, as well as a 50% reduction in statin-related muscle pain. Two benefits for the price of one supplement, a point that made CoQ10 popular in cardiology clinics.

Study 4: Japanese Review from 2025 on Ubiquinol

Examined a Japanese population of 280 patients treated with ubiquinol (the reduced form) at a dose of 100-150 mg per day for 16 weeks. In 65% of participants, blood pressure dropped below 130/80, even among those who previously required a second medication. The review also indicated improvement in subjective fatigue and sleep quality.

What About Metabolic Syndrome and Heart Disease?

The story of CoQ10 is not limited to blood pressure. The same endothelial effect that lowers blood pressure affects a range of interrelated conditions:

• Heart failure: The Q-SYMBIO study from 2014 showed a 43% reduction in cardiac mortality in heart failure patients treated with CoQ10. This finding alone changed the recommendations of many cardiology societies.
• Metabolic syndrome: CoQ10 improves insulin sensitivity by 15-20% in patients with insulin resistance.
• Migraine: While not directly related to blood pressure, studies have shown that a dose of 300 mg CoQ10 per day reduces migraine frequency by 50% in chronic sufferers.
• Neurodegeneration: Preliminary evidence for improvement in early Parkinson's patients, although the evidence is less strong here.

The common thread is mitochondrial health. All these diseases share a mechanism of mitochondrial dysfunction, and CoQ10 acts precisely at that point.

Should We Start Taking CoQ10?

The beautiful story needs to pass through a critical filter before a blanket recommendation. First, it is important to understand that the studies on CoQ10 and blood pressure were conducted mainly on people with existing hypertension, not on healthy individuals. If your pressure is normal, the supplement will not try to lower it further.

Second, supplement quality varies dramatically. Most trials used ubiquinol in a specific form, with the dose measured in oil capsule form. Cheap capsule supplements costing hundreds of shekels less may contain ubiquinone with low absorption, leading to disappointing results. The monthly cost of quality ubiquinol at a dose of 100-200 mg is 150-250 shekels.

Third, interactions with medications:

• Anticoagulants (Warfarin): CoQ10 is structurally similar to vitamin K and may reduce the effect of Warfarin. Requires INR monitoring.
• Blood pressure medications: Additive effect, which can lower pressure too much. Medication changes should only be made with a doctor.
• Diabetes medications: Improved insulin sensitivity can cause hypoglycemia in patients on insulin or sulfonylureas.
• Chemotherapy: Conflicting studies, with two opposing theories (CoQ10 protects or interferes), must consult with an oncologist.

Common side effects are mild nausea in 5% of users, insomnia if taken in the evening, and rare skin rash. Toxicity is very low, even at doses of 1200 mg per day in Parkinson's studies, no serious effects were observed.

What to Take Away from the Research?

1. If you suffer from mild to moderate hypertension (130-150 systolic) and do not want medication, talk to your doctor about a 12-week trial with 100-200 mg ubiquinol per day. Check blood pressure twice daily and track the change.
2. If you are taking statins, there is a double reason to add CoQ10: both lowering blood pressure and reducing muscle pain. Many cardiologists already recommend this routinely.
3. Choose ubiquinol over ubiquinone if you are over 50. Absorption is up to 4 times better in this age group.
4. Take with a meal containing fat. CoQ10 is a fat-soluble molecule, its absorption increases significantly with olive oil, avocado, or fish.
5. Do not stop your medications. CoQ10 is a complementary supplement, not a replacement. Any change in drug treatment requires close medical supervision, especially when it comes to hypertension.

The Broader Perspective

The history of CoQ10 is an excellent example of a guiding principle in the world of anti-aging supplements: the supplements that pass the test of time are those that repair a biological mechanism that deteriorates with age, not those that promise a new ability. CoQ10 does not give you something you never had; it restores what you lost. Body levels decline with age, the endothelial layer is damaged, mitochondria lose efficiency, and supplementation fills a real and measurable deficit.

This also explains why the supplement works better on older people than on young people, and why it works better on those with an existing functional problem than on perfectly healthy individuals. Quality anti-aging is often no more than structural repair of chronic damage, not improvement beyond the biological baseline. CoQ10 and blood pressure are a clear example of this principle, and that is why this supplement, which many cardiologists already recommend, continues to accumulate evidence rather than lose it.

References:
Verywell Health, Research Shows a Popular Anti-Aging Supplement May Lower Blood Pressure, April 2026